• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Latest on Human Papilloma Virus Vaccine for Cervical Cancer

  • — 7 Jan, 2006
AudioMedica News
AudioMedica News
Latest on Human Papilloma Virus Vaccine for Cervical Cancer
Latest on Human Papilloma Virus Vaccine for Cervical Cancer
00:00 /
RSS Feed
Share
Link
Embed
John Schiller
John Schiller

John Schiller, National Cancer Institute, Bethesda
The human papilloma virus vaccine, which is currently being tested in the prevention of cervical cancer, brings together both infectious disease and cancer. Delegates at the ICAAC conference heard an update on both the anti-cancer and the anti-wart activities of the two vaccines: one from Merck and the other from GlaxoSmithKline.
[audio:https://www.audiomedica.com/podcasting/icaac2005/john_schiller.mp3]

Click here for all the interviews from ICAAC 2005

You may also like...

  • Dorothea Nitsch Avoiding A Silent Killer: Simple Blood And Urine Test To Detect Early Kidney Disease 14 Aug, 2010
  • Shah Ebrahim New Research Questions Statin ‘Benefit’ In People At Low Risk Of Heart Disease 27 Jan, 2011
  • Women Just As Likely As Men To Have Tuberculosis Women Just As Likely As Men To Have Tuberculosis 16 Feb, 2010
  • Adam Bourne Research Finds HIV/AIDS Discordant Couples Face Stigma 2 Jan, 2012
  • Previous story Which Macrolide Antibiotics Provide Greatest Barrier to Resistance in Streptococcus pneumoniae?
  • Next story Fire Ants: Purveyors of Pain, or Possible Source of New Antimicrobials?
  • News

    • Liquid Biopsy ctDNA Prediction of Lung Cancer Relapse “Ready for Prime Time”Liquid Biopsy ctDNA Prediction of Lung Cancer Relapse “Ready for Prime Time”August 4, 2022
    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After Allogeneic…
    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Which Tasks Most Influence Pediatric PT Productivity,…
    • New Front Line Standard for Older Patients with Chronic…
  • Home
  • Public Health
  • ICAAC 2005
  • Latest on Human Papilloma Virus Vaccine for Cervical Cancer

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.